Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Claustrophobia

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Claustrophobia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abi-Dargham, A; Laruelle, M; Liebowitz, MR; Martinez, D; Schneier, FR; Simpson, HB; Zea-Ponce, Y1
Abi-Dargham, A; Laruelle, M; Liebowitz, MR; Lin, SH; Schneier, FR; Zea-Ponce, Y1

Other Studies

2 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Claustrophobia

ArticleYear
Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings.
    Depression and anxiety, 2008, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Age of Onset; Benzamides; Comorbidity; Control Groups; Corpus Striatum; Diagnostic and Statistical Manual of Mental Disorders; Dopamine; Humans; Middle Aged; Obsessive-Compulsive Disorder; Personality Assessment; Personality Inventory; Phobic Disorders; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon

2008
Low dopamine D(2) receptor binding potential in social phobia.
    The American journal of psychiatry, 2000, Volume: 157, Issue:3

    Topics: Adult; Benzamides; Corpus Striatum; Female; Humans; Iodine Radioisotopes; Male; Phobic Disorders; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

2000